Reteplase indications and usage: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Protected "Reteplase indications and usage": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Reteplase#Adult Indications and Dosage]]
{{Reteplase}}
{{CMG}}; {{AE}} {{AZ}}


==Indications And Usage==
[[Category: Cardiovascular Drugs]]
 
[[Category: Drug]]
Retavase® (Reteplase) is indicated for use in the management of acute [[myocardial infarction ]](AMI) in adults for the improvement of ventricular function following AMI, the reduction of the incidence of [[congestive heart failure]] and the reduction of mortality associated with AMI. Treatment should be initiated as soon as possible after the onset of AMI symptoms (see[[Reteplase clinical pharmacology|CLINICAL PHARMACOLOGY]]).<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = RETAVASE (RETEPLASE) KIT [EKR THERAPEUTICS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9ae6656-977c-4105-8528-bee664aab27a | publisher =  | date =  | accessdate =  }}</ref>
[[Category: Anticoagulants]]
 
==References==
{{Reflist}}
 
{{FDA}}
 
[[Category:Drugs]]

Latest revision as of 17:04, 20 August 2015

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Reteplase_indications_and_usage&oldid=1137413"